Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.
about
Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermineRole of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamineSulfation of the human immunodeficiency virus envelope glycoproteinThe role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cellsHIV-1 neutralizing antibodies: understanding nature's pathwaysStructural improvement of unliganded simian immunodeficiency virus gp120 core by normal-mode-based X-ray crystallographic refinementDistinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodiesBioinformatic analysis of HIV-1 entry and pathogenesis.Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formationProcessing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and ceruleninA synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusionVirus neutralisation: new insights from kinetic neutralisation curvesNonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoproteinThe ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptideStructure of an unliganded simian immunodeficiency virus gp120 coreComputer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.Analysis of the subunit stoichiometries in viral entry.Mode of action of an antiviral peptide from HIV-1. Inhibition at a post-lipid mixing stage.Estimating the stoichiometry of HIV neutralization.Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferationModifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution.Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins.Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers.Mutations within the putative membrane-spanning domain of the simian immunodeficiency virus transmembrane glycoprotein define the minimal requirements for fusion, incorporation, and infectivity.Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus.AIDS virus reverse transcriptase defined by high level expression in Escherichia coli.Mutation-directed chemical cross-linking of human immunodeficiency virus type 1 gp41 oligomers.V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical TriaPrincipal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.Furin is involved in baculovirus envelope fusion protein activation.Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cellsHuman immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusionHighly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin.
P2860
Q24615670-B6C882EC-2FD1-42AA-9E75-8296A1219115Q24633025-D53B7DB7-2539-4082-AA41-3D9EFB0C47B6Q24643931-66FF22AA-2FEE-4400-A69D-E21B7D808898Q24644271-0E7FE9A7-2ADC-458E-8BBB-A644AC344DACQ24647955-1DF06F8A-7343-4F73-8E14-D4DE2C4838DBQ24678833-3CFFE393-5321-4DF8-B3B2-36A4F45348B8Q27000480-E1F7C7F3-8FBA-4279-9550-AD2B21EBA101Q27654249-EAD10608-5EF7-44F8-A4CB-81DFDBFB06F9Q27665884-04563ED3-B4E0-477D-B354-7B313B06E4B1Q27693321-9515DD7E-8EEB-4A86-B0EB-28C059B101DAQ28302730-05E14F36-B566-4454-BA9F-4C3E2FA9DAF0Q28330684-859ED922-3D20-4A47-9D73-59D7974D81EAQ28361162-AB225F9E-251E-4059-A879-6C72572D5EE2Q28379574-5646BACF-B5B7-4876-A329-82AA7E7C403BQ28487427-CE4FA632-2FDD-4E9D-AA07-FB30FAF4CC9EQ28646731-C164F284-ED45-468C-88D4-6E61DAD9F821Q28646850-ABBC668C-5A51-4C2E-84E3-6A07CFA19980Q28646857-B31F0162-A8E7-4211-8F97-E36F1995911BQ29616089-0720D768-AD8C-4E5F-923C-56FF9413461DQ30356755-8F9FCBE3-C4EB-4D57-972E-A9E301775D44Q31053897-3C75F8AB-6EFD-4556-994D-A36B5F8696A1Q31454800-65424242-CE98-4C49-BB1F-F7CD6CA4E569Q33545224-960BEB82-3650-4EEE-9987-6A3FB16654DBQ33632668-05F8C081-2F7B-4384-BB69-960CA9D77B2EQ33685950-13F5D942-B2B0-45E5-9A95-69E0FD4D829EQ33686978-1E7EE30C-ECD1-4A4A-ADA4-421343F314A6Q33804811-1E280031-F7F5-47A6-AEAB-5DADF24158D6Q33806056-B7362193-605B-4BFB-BA5E-F656794EB004Q33836042-D5924092-4E0A-4CB7-9FE7-45B7119F66DFQ33846366-A02F0FED-2B7D-4E40-84F8-1042D1F98152Q33929366-FA5411BA-FC86-4865-9EFD-6B9B0F7865B0Q33929729-2E3195F6-A5BA-4FB8-A79E-F28BC9243B3BQ34070049-3544BA61-FE94-4AB5-867D-324B953A29AAQ34171212-82AB6D9E-E2E1-435C-89BC-83564544FE9AQ34301897-8AC9F7C8-7243-4089-823B-DCC57F1BC4A0Q34306883-13FE0413-C81E-44D4-8FE9-68D83DFDF657Q34327146-5F509B5B-0CFB-4AC4-8370-2FBDCF20822FQ34350730-7ACA8C28-EB3C-42B9-8870-23A216B3371AQ34977118-0127F738-1E91-4D02-B921-95FB875B619EQ34999293-6FCD6C7D-B488-48EF-BCCB-120B5EA95786
P2860
Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Characterization of gp41 as th ...... he HTLV-III/LAV envelope gene.
@en
Characterization of gp41 as th ...... he HTLV-III/LAV envelope gene.
@nl
type
label
Characterization of gp41 as th ...... he HTLV-III/LAV envelope gene.
@en
Characterization of gp41 as th ...... he HTLV-III/LAV envelope gene.
@nl
prefLabel
Characterization of gp41 as th ...... he HTLV-III/LAV envelope gene.
@en
Characterization of gp41 as th ...... he HTLV-III/LAV envelope gene.
@nl
P2093
P356
P1433
P1476
Characterization of gp41 as th ...... he HTLV-III/LAV envelope gene.
@en
P2093
Copeland TD
Oroszlan S
Sarngadharan MG
Veronese FD
P304
P356
10.1126/SCIENCE.2994223
P407
P50
P577
1985-09-01T00:00:00Z